The DOI matches its Crossref record; 23 of the 23 references it cites were found in a registry or an index.
Cerebrospinal fluid HIV escape associated with progressive neurologic dysfunction in patients on antiretroviral therapy with well controlled plasma viral load
Open accessAbstract
OBJECTIVE: To characterize HIV-infected patients with neurosymptomatic cerebrospinal fluid (CSF) 'escape', defined as detectable CSF HIV RNA in the setting of treatment-suppressed plasma levels or CSF RNA more than 1-log higher than plasma RNA. DESIGN: Retrospective case series. SETTING: Four urban medical centers in the United States and Europe. PARTICIPANTS: Virologically controlled HIV-infected patients on antiretroviral therapy (ART) with progressive neurologic abnormalities who were determined to have CSF 'escape'. INTERVENTION Optimization of ART based upon drug susceptibility and presumed central nervous system exposure. MAIN OUTCOME MEASURES: Levels of CSF HIV RNA and inflammatory markers, clinical signs and symptoms, and MRI findings. RESULTS: Ten patients presented with new neurologic abnormalities, which included sensory, motor, and cognitive manifestations. Median CSF HIV RNA was 3900 copies/ml (range 134-9056), whereas median plasma HIV RNA was 62 copies/ml (range <50 to 380). Median CD4 T-cell count was 482 cells/μl (range 290-660). All patients had been controlled to less than 500 copies/ml for median 27.5 months (range 2-96) and five of 10 had been suppressed to less than 50 copies/ml for median 19.5 months (range 2-96). Patients had documentation of a stable ART regimen for median 21 months (range 9-60). All had CSF pleocytosis or elevated CSF protein; seven of eight had abnormalities on MRI; and six of seven harbored CSF resistance mutations. Following optimization of ART, eight of nine patients improved clinically. CONCLUSION: The development of neurologic symptoms in patients on ART with low or undetectable plasma HIV levels may be an indication of CSF 'escape'. This study adds to a growing body of literature regarding this rare condition in well controlled HIV infection.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Updated research nosology for HIV-associated neurocognitive disorders
Antinori, A., Arendt, G., Becker, J. T., Brew, B. J., Byrd, D. A., Cherner, M., Clifford, D. B., Cinque, P., Epstein, L. G., Goodkin, K., et al. (2007) · Neurology · doi:10.1212/01.wnl.0000287431.88658.8b · Cited by 2,630 · cited 1×
“Although most patients with HIV infection do not present with neurologic symptoms, elevated HIV RNA levels in the cerebrospinal fluid (CSF) can be associated with HIV encephalitis (HIVE) and HIV-associated dementia (HAD) in patients with advanced infection [4].”
BackgroundSelf-citationThompson, M. A., Aberg, J. A., Hoy, J. F., Telenti, A., Benson, C., Cahn, P., Eron, J. J., Günthard, H. F., Hammer, S. M., Reiss, P., et al. (2012) · JAMA · doi:10.1001/jama.2012.7961 · Cited by 2,469
Heaton, R. K., Clifford, D. B., Franklin, D. R., Woods, S. P., Ake, C., Vaida, F., Ellis, R. J., Letendre, S. L., Marcotte, T. D., Atkinson, J. H., et al. (2010) · Neurology · doi:10.1212/wnl.0b013e318200d727 · Cited by 2,353
Neopterin as a Marker for Immune System Activation
Murr, C., Widner, B., Wirleitner, B., & Fuchs, D. (2002) · Current Drug Metabolism · doi:10.2174/1389200024605082 · Cited by 738
Self-citationThompson, M. A., Aberg, J. A., Cahn, P., Montaner, J. S. G., Rizzardini, G., Telenti, A., Gatell, J. M., Günthard, H. F., Hammer, S. M., Hirsch, M. S., et al. (2010) · JAMA · doi:10.1001/jama.2010.1004 · Cited by 722
Cognitive dysfunction in HIV patients despite long-standing suppression of viremia
Simioni, S., Cavassini, M., Annoni, J.-M., Rimbault Abraham, A., Bourquin, I., Schiffer, V., Calmy, A., Chave, J.-P., Giacobini, E., Hirschel, B., et al. (2010) · AIDS · doi:10.1097/qad.0b013e3283354a7b · Cited by 702
Canestri, A., Lescure, F., Jaureguiberry, S., Moulignier, A., Amiel, C., Marcelin, A. G., Peytavin, G., Tubiana, R., Pialoux, G., & Katlama, C. (2010) · Clinical Infectious Diseases · doi:10.1086/650538 · Cited by 405
Ellis, R. J., Hsia, K., Spector, S. A., Nelson, J. A., Heaton, R. K., Wallace, M. R., Abramson, I., Atkinson, J. H., Grant, I., & McCutchan, J. A. (1997) · Annals of Neurology · doi:10.1002/ana.410420503 · Cited by 321
HIV‐1 Viral Escape in Cerebrospinal Fluid of Subjects on Suppressive Antiretroviral Treatment
Edén, A., Fuchs, D., Hagberg, L., Nilsson, S., Spudich, S., Svennerholm, B., Price, R. W., & Gisslén, M. (2010) · The Journal of Infectious Diseases · doi:10.1086/657342 · Cited by 286
Self-citationSmurzynski, M., Wu, K., Letendre, S., Robertson, K., Bosch, R. J., Clifford, D. B., Evans, S., Collier, A. C., Taylor, M., & Ellis, R. (2011) · AIDS · doi:10.1097/qad.0b013e32834171f8 · Cited by 218
Hagberg, L., Cinque, P., Gisslen, M., Brew, B. J., Spudich, S., Bestetti, A., Price, R. W., & Fuchs, D. (2010) · AIDS Research and Therapy · doi:10.1186/1742-6405-7-15 · Cited by 216
Self-citationDetermination of neopterin in serum and urine.
Werner, E. R., Bichler, A., Daxenbichler, G., Fuchs, D., Fuith, L. C., Hausen, A., Hetzel, H., Reibnegger, G., & Wachter, H. (1987) · Clinical Chemistry · doi:10.1093/clinchem/33.1.62 · Cited by 189
Self-citationKatlama, C., Valantin, M. A., Algarte-Genin, M., Duvivier, C., Lambert-Niclot, S., Girard, P. M., Molina, J. M., Hoen, B., Pakianather, S., Peytavin, G., et al. (2010) · AIDS · doi:10.1097/qad.0b013e32833dec20 · Cited by 166
Spudich, S. S., Nilsson, A. C., Lollo, N. D., Liegler, T. J., Petropoulos, C. J., Deeks, S. G., Paxinos, E. E., & Price, R. W. (2005) · BMC Infectious Diseases · doi:10.1186/1471-2334-5-98 · Cited by 161
Self-citationSevere, demyelinating leukoencephalopathy in AIDS patients on antiretroviral therapy
Langford, T. D., Letendre, S. L., Marcotte, T. D., Ellis, R. J., McCutchan, J. A., Grant, I., Mallory, M. E., Hansen, L. A., Archibald, S., Jernigan, T., et al. (2002) · AIDS · doi:10.1097/00002030-200205030-00008 · Cited by 160
Cunningham, P., Smith, D. G., Satchell, C. S., Cooper, D. A., & Brew, B. J. (2000) · AIDS · doi:10.1097/00002030-200009080-00010 · Cited by 138
Antiretroviral Therapy and Central Nervous System HIV Type 1 Infection
Price, R. W., & Spudich, S. (2008) · The Journal of Infectious Diseases · doi:10.1086/533419 · Cited by 131
Self-citationCerebral CD8+ lymphocytosis in HIV-1 infected patients with immune restoration induced by HAART
Miller, R. F., Isaacson, P. G., Hall-Craggs, M. A., Lucas, S. B., Gray, F., Scaravilli, F., & An, S. (2004) · Acta Neuropathologica · doi:10.1007/s00401-004-0852-0 · Cited by 116
Wirleitner, B., Schroecksnadel, K., Winkler, C., & Fuchs, D. (2004) · Molecular Immunology · doi:10.1016/j.molimm.2004.06.017 · Cited by 97
Self-citationGisslén, M., Fuchs, D., Svennerholm, B., & Hagberg, L. (1999) · JAIDS Journal of Acquired Immune Deficiency Syndromes · doi:10.1097/00126334-199908010-00003 · Cited by 96
Self-citationSpudich, S., Lollo, N., Liegler, T. J., Deeks, S. G., & Price, R. W. (2006) · The Journal of Infectious Diseases · doi:10.1086/508750 · Cited by 94
Self-citationIndependent HIV replication in paired CSF and blood viral isolates during antiretroviral therapy
Stingele, K., Haas, J., Zimmermann, T. P., Stingele, R., Hübsch-Müller, C., Freitag, M., Storch-Hagenlocher, B., Hartmann, M., & Wildemann, B. (2001) · Neurology · doi:10.1212/wnl.56.3.355 · Cited by 72
Reversible dementia in a patient with central nervous system escape of human immunodeficiency virus
Bogoch, I. I., Davis, B. T., & Venna, N. (2011) · Journal of Infection · doi:10.1016/j.jinf.2011.05.011 · Cited by 33
Cited by
HIV-associated neurocognitive disorder
Clifford, D. B., & Ances, B. M. (2013) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(13)70269-x · Cited by 670
Gisslén, M., Price, R. W., Andreasson, U., Norgren, N., Nilsson, S., Hagberg, L., Fuchs, D., Spudich, S., Blennow, K., & Zetterberg, H. (2016) · EBioMedicine · doi:10.1016/j.ebiom.2015.11.036 · Cited by 481
Self-citationHIV-1-associated neurocognitive disorder: epidemiology, pathogenesis, diagnosis, and treatment
For the German Association of Neuro-AIDS und Neuro-Infectiology (DGNANI), Eggers, C., Arendt, G., Hahn, K., Husstedt, I. W., Maschke, M., Neuen-Jacob, E., Obermann, M., Rosenkranz, T., Schielke, E., et al. (2017) · Journal of Neurology · doi:10.1007/s00415-017-8503-2 · Cited by 339
HIV reservoirs: what, where and how to target them
Churchill, M. J., Deeks, S. G., Margolis, D. M., Siliciano, R. F., & Swanstrom, R. (2016) · Nature Reviews Microbiology · doi:10.1038/nrmicro.2015.5 · Cited by 313
Controversies in HIV-associated neurocognitive disorders
Nightingale, S., Winston, A., Letendre, S., Michael, B. D., McArthur, J. C., Khoo, S., & Solomon, T. (2014) · The Lancet Neurology · doi:10.1016/s1474-4422(14)70137-1 · Cited by 294
Metadata
- Authors
- Peluso, M. J., Ferretti, F., Peterson, J., Lee, E., Fuchs, D., Boschini, A., Gisslén, M., Angoff, N., Price, R. W., Cinque, P., & Spudich, S.
- Venue
- AIDS
- Published
- 2012-09-10
- Volume
- 26
- Issue
- 14
- Pages
- 1765-1774
- ISSN
- 0269-9370 (ISSN-L)
- OpenAlex
- W2049436090
- Cited by
- 252
- References
- 23
- FWCI
- 6.98
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.